A role for T-cell exhaustion in Long COVID-19 and severe outcomes for several categories of COVID-19 patients

被引:20
|
作者
Roe, Kevin
机构
[1] San Jose, CA
关键词
brain infections; latent infections; protozoa; protozoan infections; SARS-CoV-2; mortality; INHIBITION; INFECTION;
D O I
10.1002/jnr.24917
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Unusual mortality rate differences and symptoms have been experienced by COVID-19 patients, and the postinfection symptoms called Long COVID-19 have also been widely experienced. A substantial percentage of COVID-19-infected individuals in specific health categories have been virtually asymptomatic, several other individuals in the same health categories have exhibited several unusual symptoms, and yet other individuals in the same health categories have fatal outcomes. It is now hypothesized that these differences in mortality rates and symptoms could be caused by a SARS-CoV-2 virus infection acting together with one or more latent pathogen infections in certain patients, through mutually beneficial induced immune cell dysfunctions, including T-cell exhaustion. A latent pathogen infection likely to be involved is the protozoan parasite Toxoplasma gondii, which infects approximately one third of the global human population. Furthermore, certain infections and cancers that cause T-cell exhaustion can also explain the more severe outcomes of other COVID-19 patients having several disease and cancer comorbidities.
引用
收藏
页码:2367 / 2376
页数:10
相关论文
共 50 条
  • [2] T-cell count and T-cell telomere length in patients with severe COVID-19
    Kraft, Bryan D.
    Verhulst, Simon
    Lai, Tsung-Po
    Sullenger, Bruce A.
    Wang, Yunfei
    Rountree, Wes
    Chen, Lingye
    Woods, Christopher W.
    Denny, Thomas N.
    Aviv, Abraham
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [3] COVID-19: room for treating T cell exhaustion?
    Giovanni Riva
    Vincenzo Nasillo
    Enrico Tagliafico
    Tommaso Trenti
    Mario Luppi
    Critical Care, 24
  • [4] COVID-19: room for treating T cell exhaustion?
    Riva, Giovanni
    Nasillo, Vincenzo
    Tagliafico, Enrico
    Trenti, Tommaso
    Luppi, Mario
    CRITICAL CARE, 2020, 24 (01):
  • [5] T-cell dysregulation in COVID-19
    Kalfaoglu, Bahire
    Almeida-Santos, Jose
    Tye, Chanidapa Adele
    Satou, Yorifumi
    Ono, Masahiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 204 - 210
  • [6] Lymphocytic exhaustion in Covid-19 patients
    De Diego Ramos, C.
    Torralba, L.
    Lopez, L.
    Ruiz De Gopegui, P.
    Lahoz, R.
    Abadia, C.
    Lasierra, A.
    Cebollada, A.
    Godino, J.
    Jimeno, B.
    Bello, S.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [7] Severe COVID-19 outcomes in patients with psoriasis
    Lima, X. T.
    Cueva, M. A.
    Lopes, E. M.
    Alora, M. B.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (12) : E776 - E778
  • [8] Clinical outcomes in a cohort of patients with cutaneous T-cell lymphoma and COVID-19
    Runge, John S.
    Bardhi, Redina
    Xia, Yang
    Jairath, Neil K.
    Wilcox, Ryan A.
    Tsoi, Lam C.
    Tejasvi, Trilokraj
    JAAD INTERNATIONAL, 2022, 8 : 52 - 55
  • [9] Response to "COVID-19: room for treating T cell exhaustion?"
    Drewry, Anne M.
    Hotchkiss, Richard
    Kulstad, Erik
    CRITICAL CARE, 2020, 24 (01):
  • [10] Response to “COVID-19: room for treating T cell exhaustion?”
    Anne M. Drewry
    Richard Hotchkiss
    Erik Kulstad
    Critical Care, 24